Literature DB >> 28206683

A perspective on malignancy in the marrow.

Michaela R Reagan1,2,3, Jane B Lian4, Clifford J Rosen1,2,3, Gary S Stein4.   

Abstract

Malignancies that grow in the bone marrow cause a cascade of devastating consequences and are almost always fatal. For researchers to make significant headway in finding cures and treatments for these tumors and the subsequent devastation of cancer-induced bone disease, novel strategies and creative solutions will have to be considered. Great progress has been made in treating hematologic and sold tumor malignancies that ultimately affect the bone marrow, although it is also obvious that multi-disciplinary teams are required to ultimately win the war on cancers that affect the bone. In this perspective, we review recent advances in the identification of molecular and cellular targets in the bone marrow niche.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  bone marrow niche; bone metastasis; microenvironment; tumor

Mesh:

Year:  2017        PMID: 28206683      PMCID: PMC5559340          DOI: 10.1002/jcp.25860

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

1.  Oncofetal Epigenetic Bivalency in Breast Cancer Cells: H3K4 and H3K27 Tri-Methylation as a Biomarker for Phenotypic Plasticity.

Authors:  Terri L Messier; Joseph R Boyd; Jonathan A R Gordon; Janet L Stein; Jane B Lian; Gary S Stein
Journal:  J Cell Physiol       Date:  2016-03-10       Impact factor: 6.384

Review 2.  An update on the role of daratumumab in the treatment of multiple myeloma.

Authors:  Caitlin Costello
Journal:  Ther Adv Hematol       Date:  2016-11-24

3.  The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma.

Authors:  Siobhan V Glavey; Salomon Manier; Alessandro Natoni; Antonio Sacco; Michele Moschetta; Michaela R Reagan; Laura S Murillo; Ilyas Sahin; Ping Wu; Yuji Mishima; Yu Zhang; Wenjing Zhang; Yong Zhang; Gareth Morgan; Lokesh Joshi; Aldo M Roccaro; Irene M Ghobrial; Michael E O'Dwyer
Journal:  Blood       Date:  2014-07-24       Impact factor: 22.113

4.  Tissue-engineered 3D cancer-in-bone modeling: silk and PUR protocols.

Authors:  Ushashi Dadwal; Carolyne Falank; Heather Fairfield; Sarah Linehan; Clifford J Rosen; David L Kaplan; Julie Sterling; Michaela R Reagan
Journal:  Bonekey Rep       Date:  2016-10-19

5.  Engineered nanomedicine for myeloma and bone microenvironment targeting.

Authors:  Archana Swami; Michaela R Reagan; Pamela Basto; Yuji Mishima; Nazila Kamaly; Siobhan Glavey; Sufeng Zhang; Michele Moschetta; Dushanth Seevaratnam; Yong Zhang; Jinhe Liu; Masoumeh Memarzadeh; Jun Wu; Salomon Manier; Jinjun Shi; Nicolas Bertrand; Zhi Ning Lu; Kenichi Nagano; Roland Baron; Antonio Sacco; Aldo M Roccaro; Omid C Farokhzad; Irene M Ghobrial
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

6.  A proteasome inhibitor, bortezomib, inhibits breast cancer growth and reduces osteolysis by downregulating metastatic genes.

Authors:  Marci D Jones; Julie C Liu; Thomas K Barthel; Sadiq Hussain; Erik Lovria; Dengfeng Cheng; Jesse A Schoonmaker; Sudhanshu Mulay; David C Ayers; Mary L Bouxsein; Gary S Stein; Siddhartha Mukherjee; Jane B Lian
Journal:  Clin Cancer Res       Date:  2010-09-15       Impact factor: 12.531

7.  Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate.

Authors:  Yi Fan; Jun-Ichi Hanai; Phuong T Le; Ruiye Bi; David Maridas; Victoria DeMambro; Carolina A Figueroa; Serkan Kir; Xuedong Zhou; Michael Mannstadt; Roland Baron; Roderick T Bronson; Mark C Horowitz; Joy Y Wu; John P Bilezikian; David W Dempster; Clifford J Rosen; Beate Lanske
Journal:  Cell Metab       Date:  2017-02-02       Impact factor: 27.287

Review 8.  Navigating the bone marrow niche: translational insights and cancer-driven dysfunction.

Authors:  Michaela R Reagan; Clifford J Rosen
Journal:  Nat Rev Rheumatol       Date:  2015-11-26       Impact factor: 20.543

Review 9.  Role of endothelial progenitor cells in cancer progression.

Authors:  Michele Moschetta; Yuji Mishima; Ilyas Sahin; Salomon Manier; Siobhan Glavey; Angelo Vacca; Aldo M Roccaro; Irene M Ghobrial
Journal:  Biochim Biophys Acta       Date:  2014-04-04

10.  Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma.

Authors:  Jesus Delgado-Calle; Judith Anderson; Meloney D Cregor; Masahiro Hiasa; John M Chirgwin; Nadia Carlesso; Toshiyuki Yoneda; Khalid S Mohammad; Lilian I Plotkin; G David Roodman; Teresita Bellido
Journal:  Cancer Res       Date:  2016-02-01       Impact factor: 12.701

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.